Clinical, ECG, and echocardiographic characteristics of affected subjects
| No | Age (y) | Sex (M/F) | ECG | Max IVS (mm) | Spirito score (mm) | Maron type | Gene mutation |
|---|---|---|---|---|---|---|---|
| I.3 | 84 | F | Ventricular pacing | 25 | 67 | III | MYH7 |
| II.1 | 56 | F | LVH, negative T waves | 32 | 85 | III | MYH7/MYBPC3 |
| II.2 | 58 | M | Normal | 15 | 49 | II | MYH7 |
| II.3 | 62 | F | Normal | 21 | 61 | III | MYH7 |
| III.1 | 30 | F | Negative T waves (V2-4) | 20 | 63 | III | MYBPC3 |
| III.3 | 31 | M | Negative T waves (V2-4) | 19 | 63 | III | MYH7 |
| III.5 | 33 | M | LVH, negative T waves | 28 | 75 | III | MYH7/MYBPC3 |
| III.8 | 27 | F | Normal | 17 | 52 | III | MYBPC3 |
Max IVS: maximal end diastolic interventricular wall thickness. Maron type: type II hypertrophy involving both the anterior and posterior segments of the interventricular septum, type III hypertrophy involving both the interventricular septum and the left ventricular free wall.